Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06532487 · ClinicalTrials.gov registry record · NA
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
A NA study of Health Harming Legal Needs, sponsored by Stony Brook University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,140
- Enrollment target
- 1
- Study location
NCT06532487: Recruiting NA study of Health Harming Legal Needs, sponsored by Stony Brook University.
NCT06532487 is a NA study of Health Harming Legal Needs that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 1,140 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06532487, a NA study of Health Harming Legal Needs, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,140 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will examine the effects of legal services on primary care outcomes for medically underserved communities. The aims of the study are: 1. To test the effectiveness and cost-benefits of a critical-time intervention Medical-Legal Partnership (CTI-MLP) on patient outcomes. 2. To determine the most efficient mechanisms for CTI-MLP delivery. 3. To develop innovative community engagement strategies for addressing health-harming legal needs within community health centers. Eligible patients will be asked to complete a questionnaire 4 times, first when they join the study and then at 3 months, 6 months, and 12 months. In the survey, they will be asked to provide information about themselves, their health care, aspects of their daily life, and hardships they face. They will also allow researchers to access their electronic health record information housed in the community-based organization and attorney notes. Patient information will be completely confidential and de-identified, meaning, the research team will not know the identity of the person who answered the questions. Participating community health centers will be randomized (assigned by chance) to provide basic legal information and referral to legal aid; or have an attorney on-site to provide legal aid to those who screen for legal needs.
Primary Outcome
PROMIS Global Health-10, a self-administered measured included in the survey described below. It includes general domains of health and functioning including overall physical health, mental health, social health, pain, fatigue, and overall perceived quality of life.
Conditions Studied
Interventions
- OTHER Critical Time Medical-Legal Partnership Intervention
Study Locations (1)
New York
- Betances Health Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,140 participants |
| Start Date | 2024-11-28 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06532487 shows while recruiting
NCT06532487 is an interventional study that assigns participants to a tested intervention. Its 1,140 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (19% lower).
The record links to 1 condition, with Health Harming Legal Needs appearing as the primary indexed condition, and to 1 intervention - of which Critical Time Medical-Legal Partnership Intervention is the first listed.
NCT06532487 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06532487 about?
NCT06532487 is a clinical study titled "Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities". This clinical trial will examine the effects of legal services on primary care outcomes for medically underserved communities. The aims of the study are: 1. To test the effectiveness and cost-benefits of a critical-time intervention Medical-Legal Partnership (CTI-MLP) on patient outcomes. 2. To de...
What is the current status of trial NCT06532487?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,140 participants. The study started on 2024-11-28. Estimated completion is 2027-06.
What conditions does trial NCT06532487 study?
This clinical trial studies the following conditions: Health Harming Legal Needs.
What interventions are being tested in trial NCT06532487?
The interventions under investigation include: Critical Time Medical-Legal Partnership Intervention (OTHER).
Who is sponsoring clinical trial NCT06532487?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06532487 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06532487's enrollment target sits among peer trials
1,140 92nd of 2000 higher than 1,908 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05894967 · 1,140 participants · NA
Moderators and Mediators of Perceptual Learning
- NCT06129864 · 1,145 participants · Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
- NCT06676319 · 1,147 participants · Phase 2
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI